|
시장보고서
상품코드
1872154
원격정신과 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)Telepsychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 원격정신과 시장 규모는 2024년에 7억 1,300만 달러로 추정되며, 2025-2031년의 예측 기간 중 CAGR 22.1%로 성장하며, 2031년까지 29억 5,800만 달러로 확대할 것으로 예측됩니다.
원격정신과는 화상회의, 음성통신, 디지털 플랫폼을 통해 원격으로 정신과 의료를 제공하는 원격의료의 한 형태입니다. 진단 평가, 약물 치료 관리, 개인 및 그룹 치료, 환자 교육, 후속 조치 등 다양한 서비스를 포함합니다. 원격 정신의료는 특히 지방이나 원격지, 의료서비스가 부족한 지역에서 정신보건 서비스에 대한 접근성을 크게 개선하고 정신의료 수요 및 공급의 격차를 해소하는 데 도움이 될 수 있습니다. 클라우드 기반 플랫폼, AI 지원 진단, 전자건강기록(EHR)의 통합으로 원격 정신의료는 정신보건 서비스의 디지털 혁신과 확장에 있으며, 중요한 원동력이 되고 있습니다.
포스트 팬데믹 시대에 우울증, 불안장애, 청소년기 정신장애가 주요 공중보건 문제로 떠오르면서 정신건강 서비스에 대한 전 세계적인 수요는 계속 증가하고 있습니다. CDC, NHS, 중국 국가위생건강위원회의 데이터에 따르면 원격 정신 의료는 현재 정부가 광범위한 정신 헬스케어의 보급을 촉진하기 위한 핵심 툴이 되고 있습니다. 주요 의료 프로바이더(Kaiser Permanente, Mayo Clinic 등), 테크 플랫폼(Teradoc Health, MDLive 등), 지역 의료 시스템은 원격 정신의료에 대한 투자를 확대하고 있습니다. AI를 활용한 사전 스크리닝, 개인 맞춤형 치료 알고리즘, 전자건강기록(EHR)과의 긴밀한 연계가 업계의 빠른 성장을 촉진하고 있습니다. 보험 상환 정책의 완화(예: 미국 메디케어의 확대)와 기업 웰니스 프로그램 예산 증가는 시장 침투를 더욱 가속화하고 있습니다.
급속한 보급에도 불구하고 원격 정신의료는 여전히 해결해야 할 과제가 존재합니다. 구체적으로는 의사와 환자 간의 약한 연결, 데이터 보안에 대한 우려, 의료 종사자의 복잡한 지역 간 라이선싱 등을 꼽을 수 있습니다. 많은 개발도상국에서는 불충분한 디지털 인프라, 숙련된 전문가 부족, 미발달된 결제 시스템 등이 보급을 제한하고 있습니다. 또한 이 산업은 정책의 영향을 받기 쉬우며, 상환 규칙의 강화와 규제 완화는 시장의 변동성을 유발할 수 있습니다.
기업 임직원 웰니스 프로그램, 노인 정신건강 서비스, 학교 상담 플랫폼, 청소년 행동치료 등이 가장 빠르게 성장하고 있는 응용 분야입니다. 보험사, 기업 건강관리 플랫폼, 교육기관, 주요 HMO(Health Maintenance Organization)가 원격 정신의료 서비스의 주요 구매자가 되고 있습니다. 향후 적응형 AI 기반 치료 시스템, 24시간 365일 운영되는 가상 정신과 클리닉, 모바일 기반 정신건강 앱(챗봇 등)이 산업의 미래를 형성할 것으로 예측됩니다.
이 보고서는 세계 원격 정신의료 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총매출액, 주요 기업의 시장 점유율과 순위에 초점을 맞추고, 지역별, 국가별, 유형별, 최종사용자별 원격 정신의료 분석을 포함합니다.
이 보고서는 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 바탕으로 텔레사이클 시장 규모, 추정 및 예측을 매출로 제시합니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 구도를 평가하고, 현재 시장에서의 자사 위치를 분석하여, 텔레사이언티스트리에 대한 정보에 입각한 비즈니스 의사결정을 내리는데 도움을 드리고자 합니다.
시장 세분화
기업별
- Teladoc Health
- American Telepsychiatrists
- American Well
- Doxy.me
- Advanced Telemed Services
- Cerebral
- Talkiatry
- Talkspace
- Arcadian Telepsychiatry
- MDLIVE Behavioral Health
- Thriveworks
- Lyra Health
- Psychiatric Alternatives
- MyndYou
- PlushCare
유형별 부문
- 일상 원격정신과
- 법정 원격정신과
- 위기 대응 원격정신과
- 재택 원격정신과
최종사용자별 부문
- 성인
- 십대
- 고령자층
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for Telepsychiatry was estimated to be worth US$ 713 million in 2024 and is forecast to a readjusted size of US$ 2958 million by 2031 with a CAGR of 22.1% during the forecast period 2025-2031.
Telepsychiatry is a form of telemedicine that enables the remote delivery of psychiatric care through video conferencing, voice communication, and digital platforms. It encompasses a wide range of services including diagnostic assessments, medication management, individual and group therapy, as well as patient education and follow-up. Telepsychiatry significantly improves access to mental health services, particularly in rural, remote, or underserved areas, and helps to bridge the gap between demand and supply of psychiatric care. With the integration of cloud-based platforms, AI-assisted diagnostics, and electronic health records (EHRs), telepsychiatry is becoming a vital driver in the digital transformation and expansion of mental health services.
In the post-pandemic era, global demand for mental health services continues to rise, with depression, anxiety, and adolescent mental disorders becoming major public health concerns. According to data from the CDC, NHS, and China's National Health Commission, telepsychiatry is now a core tool for governments to promote widespread mental health coverage. Major healthcare providers (e.g., Kaiser Permanente, Mayo Clinic), tech platforms (e.g., Teladoc Health, MDLive), and regional health systems are expanding investments in telepsychiatry. AI-powered pre-screening, personalized therapy algorithms, and deeper integration with EHRs are fueling rapid industry growth. Relaxation of reimbursement policies (e.g., U.S. Medicare expansion) and increased budgets for corporate wellness programs further accelerate market penetration.
Despite rapid adoption, telepsychiatry faces notable challenges, including weaker doctor-patient connections, concerns over data security, and complex cross-regional licensing for practitioners. In many developing countries, insufficient digital infrastructure, lack of trained professionals, and underdeveloped payment systems limit adoption. Moreover, the industry is policy-sensitive-any tightening of reimbursement rules or regulatory rollback could trigger market volatility.
Enterprise employee wellness programs, elderly mental care services, school counseling platforms, and adolescent behavioral therapy are among the fastest-growing application areas. Insurance companies, employer health platforms, educational institutions, and major HMOs are becoming key purchasers of telepsychiatry services. Looking ahead, adaptive AI-driven therapy systems, 24/7 virtual psychiatric clinics, and mobile-based mental health apps (like chatbots) are expected to shape the future of the industry.
This report aims to provide a comprehensive presentation of the global market for Telepsychiatry, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Telepsychiatry by region & country, by Type, and by End User.
The Telepsychiatry market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telepsychiatry.
Market Segmentation
By Company
- Teladoc Health
- American Telepsychiatrists
- American Well
- Doxy.me
- Advanced Telemed Services
- Cerebral
- Talkiatry
- Talkspace
- Arcadian Telepsychiatry
- MDLIVE Behavioral Health
- Thriveworks
- Lyra Health
- Psychiatric Alternatives
- MyndYou
- PlushCare
Segment by Type
- Routine Telepsychiatry
- Forensic Telepsychiatry
- Crisis Telepsychiatry
- In-Home Telepsychiatry
Segment by End User
- Adults
- Teenagers
- Geriatric Populations
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Telepsychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Telepsychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Telepsychiatry in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Telepsychiatry Product Introduction
- 1.2 Global Telepsychiatry Market Size Forecast (2020-2031)
- 1.3 Telepsychiatry Market Trends & Drivers
- 1.3.1 Telepsychiatry Industry Trends
- 1.3.2 Telepsychiatry Market Drivers & Opportunity
- 1.3.3 Telepsychiatry Market Challenges
- 1.3.4 Telepsychiatry Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Telepsychiatry Players Revenue Ranking (2024)
- 2.2 Global Telepsychiatry Revenue by Company (2020-2025)
- 2.3 Key Companies Telepsychiatry Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Telepsychiatry Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Telepsychiatry
- 2.6 Telepsychiatry Market Competitive Analysis
- 2.6.1 Telepsychiatry Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Telepsychiatry Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telepsychiatry as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Routine Telepsychiatry
- 3.1.2 Forensic Telepsychiatry
- 3.1.3 Crisis Telepsychiatry
- 3.1.4 In-Home Telepsychiatry
- 3.2 Global Telepsychiatry Sales Value by Type
- 3.2.1 Global Telepsychiatry Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Telepsychiatry Sales Value, by Type (2020-2031)
- 3.2.3 Global Telepsychiatry Sales Value, by Type (%) (2020-2031)
4 Segmentation by End User
- 4.1 Introduction by End User
- 4.1.1 Adults
- 4.1.2 Teenagers
- 4.1.3 Geriatric Populations
- 4.2 Global Telepsychiatry Sales Value by End User
- 4.2.1 Global Telepsychiatry Sales Value by End User (2020 VS 2024 VS 2031)
- 4.2.2 Global Telepsychiatry Sales Value, by End User (2020-2031)
- 4.2.3 Global Telepsychiatry Sales Value, by End User (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Telepsychiatry Sales Value by Region
- 5.1.1 Global Telepsychiatry Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Telepsychiatry Sales Value by Region (2020-2025)
- 5.1.3 Global Telepsychiatry Sales Value by Region (2026-2031)
- 5.1.4 Global Telepsychiatry Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Telepsychiatry Sales Value, 2020-2031
- 5.2.2 North America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Telepsychiatry Sales Value, 2020-2031
- 5.3.2 Europe Telepsychiatry Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Telepsychiatry Sales Value, 2020-2031
- 5.4.2 Asia Pacific Telepsychiatry Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Telepsychiatry Sales Value, 2020-2031
- 5.5.2 South America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Telepsychiatry Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Telepsychiatry Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Telepsychiatry Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Telepsychiatry Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Telepsychiatry Sales Value, 2020-2031
- 6.3.2 United States Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Telepsychiatry Sales Value, 2020-2031
- 6.4.2 Europe Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.5 China
- 6.5.1 China Telepsychiatry Sales Value, 2020-2031
- 6.5.2 China Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Telepsychiatry Sales Value, 2020-2031
- 6.6.2 Japan Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Telepsychiatry Sales Value, 2020-2031
- 6.7.2 South Korea Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Telepsychiatry Sales Value, 2020-2031
- 6.8.2 Southeast Asia Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Telepsychiatry Sales Value by End User, 2024 VS 2031
- 6.9 India
- 6.9.1 India Telepsychiatry Sales Value, 2020-2031
- 6.9.2 India Telepsychiatry Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Telepsychiatry Sales Value by End User, 2024 VS 2031
7 Company Profiles
- 7.1 Teladoc Health
- 7.1.1 Teladoc Health Profile
- 7.1.2 Teladoc Health Main Business
- 7.1.3 Teladoc Health Telepsychiatry Products, Services and Solutions
- 7.1.4 Teladoc Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.1.5 Teladoc Health Recent Developments
- 7.2 American Telepsychiatrists
- 7.2.1 American Telepsychiatrists Profile
- 7.2.2 American Telepsychiatrists Main Business
- 7.2.3 American Telepsychiatrists Telepsychiatry Products, Services and Solutions
- 7.2.4 American Telepsychiatrists Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.2.5 American Telepsychiatrists Recent Developments
- 7.3 American Well
- 7.3.1 American Well Profile
- 7.3.2 American Well Main Business
- 7.3.3 American Well Telepsychiatry Products, Services and Solutions
- 7.3.4 American Well Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.3.5 American Well Recent Developments
- 7.4 Doxy.me
- 7.4.1 Doxy.me Profile
- 7.4.2 Doxy.me Main Business
- 7.4.3 Doxy.me Telepsychiatry Products, Services and Solutions
- 7.4.4 Doxy.me Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.4.5 Doxy.me Recent Developments
- 7.5 Advanced Telemed Services
- 7.5.1 Advanced Telemed Services Profile
- 7.5.2 Advanced Telemed Services Main Business
- 7.5.3 Advanced Telemed Services Telepsychiatry Products, Services and Solutions
- 7.5.4 Advanced Telemed Services Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.5.5 Advanced Telemed Services Recent Developments
- 7.6 Cerebral
- 7.6.1 Cerebral Profile
- 7.6.2 Cerebral Main Business
- 7.6.3 Cerebral Telepsychiatry Products, Services and Solutions
- 7.6.4 Cerebral Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.6.5 Cerebral Recent Developments
- 7.7 Talkiatry
- 7.7.1 Talkiatry Profile
- 7.7.2 Talkiatry Main Business
- 7.7.3 Talkiatry Telepsychiatry Products, Services and Solutions
- 7.7.4 Talkiatry Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.7.5 Talkiatry Recent Developments
- 7.8 Talkspace
- 7.8.1 Talkspace Profile
- 7.8.2 Talkspace Main Business
- 7.8.3 Talkspace Telepsychiatry Products, Services and Solutions
- 7.8.4 Talkspace Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.8.5 Talkspace Recent Developments
- 7.9 Arcadian Telepsychiatry
- 7.9.1 Arcadian Telepsychiatry Profile
- 7.9.2 Arcadian Telepsychiatry Main Business
- 7.9.3 Arcadian Telepsychiatry Telepsychiatry Products, Services and Solutions
- 7.9.4 Arcadian Telepsychiatry Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.9.5 Arcadian Telepsychiatry Recent Developments
- 7.10 MDLIVE Behavioral Health
- 7.10.1 MDLIVE Behavioral Health Profile
- 7.10.2 MDLIVE Behavioral Health Main Business
- 7.10.3 MDLIVE Behavioral Health Telepsychiatry Products, Services and Solutions
- 7.10.4 MDLIVE Behavioral Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.10.5 MDLIVE Behavioral Health Recent Developments
- 7.11 Thriveworks
- 7.11.1 Thriveworks Profile
- 7.11.2 Thriveworks Main Business
- 7.11.3 Thriveworks Telepsychiatry Products, Services and Solutions
- 7.11.4 Thriveworks Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.11.5 Thriveworks Recent Developments
- 7.12 Lyra Health
- 7.12.1 Lyra Health Profile
- 7.12.2 Lyra Health Main Business
- 7.12.3 Lyra Health Telepsychiatry Products, Services and Solutions
- 7.12.4 Lyra Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.12.5 Lyra Health Recent Developments
- 7.13 Psychiatric Alternatives
- 7.13.1 Psychiatric Alternatives Profile
- 7.13.2 Psychiatric Alternatives Main Business
- 7.13.3 Psychiatric Alternatives Telepsychiatry Products, Services and Solutions
- 7.13.4 Psychiatric Alternatives Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.13.5 Psychiatric Alternatives Recent Developments
- 7.14 MyndYou
- 7.14.1 MyndYou Profile
- 7.14.2 MyndYou Main Business
- 7.14.3 MyndYou Telepsychiatry Products, Services and Solutions
- 7.14.4 MyndYou Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.14.5 MyndYou Recent Developments
- 7.15 PlushCare
- 7.15.1 PlushCare Profile
- 7.15.2 PlushCare Main Business
- 7.15.3 PlushCare Telepsychiatry Products, Services and Solutions
- 7.15.4 PlushCare Telepsychiatry Revenue (US$ Million) & (2020-2025)
- 7.15.5 PlushCare Recent Developments
8 Industry Chain Analysis
- 8.1 Telepsychiatry Industrial Chain
- 8.2 Telepsychiatry Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Telepsychiatry Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Telepsychiatry Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
